A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye

D. Y. Nishimura, C. C. Searby, W. L. Alward, D. Walton, J. E. Craig, D. A. Mackey, K. Kawase, A. B. Kanis, S. R. Patil, E. M. Stone, V. C. Sheffield

Research output: Contribution to journalArticlepeer-review

176 Citations (Scopus)

Abstract

Mutations in the forkhead transcription-factor gene (FOXC1), have been shown to cause defects of the anterior chamber of the eye that are associated with developmental forms of glaucoma. Discovery of these mutations was greatly facilitated by the cloning and characterization of the 6p25 breakpoint in a patient with both congenital glaucoma and a balanced-translocation event involving chromosomes 6 and 13. Here we describe the identification of novel mutations in the FOXC1 gene in patients with anterior-chamber defects of the eye. We have detected nine new mutations (eight of which are novel) in the FOXC1 gene in patients with anterior-chamber eye defects. Of these mutations, five frameshift mutations predict loss of the forkhead domain, as a result of premature termination of translation. Of particular interest is the fact that two families have a duplication of 6p25, involving the FOXC1 gene. These data suggest that both FOXC1 haploinsufficiency and increased gene dosage can cause anterior-chamber defects of the eye.

Original languageEnglish
Pages (from-to)364-372
Number of pages9
JournalAmerican Journal of Human Genetics
Volume68
Issue number2
DOIs
Publication statusPublished - 1 Jan 2001
Externally publishedYes

Fingerprint

Dive into the research topics of 'A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye'. Together they form a unique fingerprint.

Cite this